Am Heart J

1. MARINACCI LX, Zheng Z, Liu M, Boyd A, et al
   Cardiometabolic health of low- and higher-income adults in the United States, 2009-2023.
   Am Heart J. 2026;301:107523.
   

   >> Share

   
   

   
   Circ Genom Precis Med

2. DESROCHES-CASTAN A, Beurier-Soulat L, Tusseau M, Coulet F, et al
   Functional and Molecular Characterization of Novel GDF2 (BMP9) and BMP10 Variants From the French PAH and HHT Cohorts.
   Circ Genom Precis Med. 2026;19:e005626.
   

   >> Share

   
   

   
   Circ Heart Fail

3. HARDIN EA, Dewanjee A, Davis P, Tedford RJ, et al
   Combined Post- and Precapillary Pulmonary Hypertension in Patients With Advanced Heart Failure.
   Circ Heart Fail. 2026 Aug 18:e014787. doi: 10.1161/CIRCHEARTFAILURE.126.014787.
   

   >> Share

   
   

   
   Diabetes Care

4. GUO T, Li H, Liu Z, Yang Y, et al
   Life Course Cumulative BMI Burden From Childhood to Adulthood and Risk of Metabolic Multimorbidity: A 36-Year Prospective Cohort Study.
   Diabetes Care. 2026;49:1567-1575.
   

   >> Share

   
   

   
   Eur J Pharmacol

5. YUAN A, Bai Y, Jiang Y, Si S, et al
   The role and mechanism of rosiglitazone in endothelial-to-mesenchymal transition in pulmonary hypertension.
   Eur J Pharmacol. 2026 Aug 21:179227. doi: 10.1016/j.ejphar.2026.179227.
   

   >> Share

   
   

   
   Hypertension

6. AGARWAL R, Correa-Rotter R, Navaneethan SD, Heerspink HJL, et al
   Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.
   Hypertension. 2026;83:e27036.
   

   >> Share

   
   
7. STERGIOU GS, Menti A, Palatini P, Parati G, et al
   Validated Automated Cuff Blood Pressure Devices for Children: STRIDE BP Report and Call to Action.
   Hypertension. 2026;83:e26206.
   

   >> Share

   
   
8. YANG J, Goi J, Burrello J, Reincke M, et al
   Primary Aldosteronism Medical Treatment Outcomes (PAMO) Beyond 12 Months.
   Hypertension. 2026;83:e27431.
   

   >> Share

   
   
9. CHEN SH, Yeh CY, Chiang-Lin YP, Huang CJ, et al
   Clinical Modifiers of Salt Sensitivity: A Meta-Regression and Risk Translation Study.
   Hypertension. 2026;83:e27410.
   

   >> Share

   
   
10. LIANG W, Liu Q, Wang Q, Wang W, et al
    Renal Denervation Modulates Hypothalamic Neuroinflammation via P2X7R/PI3K/Akt.
    Hypertension. 2026;83:e26793.
    

    >> Share

    
    
11. YANG T
    2024 Donald Seldin Lecture: New Insights Into Soluble (Pro)Renin Receptor in Hypertension and Kidney Disease.
    Hypertension. 2026 Aug 17. doi: 10.1161/HYPERTENSIONAHA.126.25708.
    

    >> Share

    
    
12. TANG R, An J, Moran AE, Shimbo D, et al
    Isolated Diastolic Hypertension and Cardiovascular Disease Risk in Young Adults.
    Hypertension. 2026 Aug 17:10.1161/HYPERTENSIONAHA.126.27333.
    

    >> Share

    
    
13. DANIELLI M, Munroe PB
    Resistant Hypertension: A Genetic Window on Aldosterone, Potassium, and Missed Clinical Opportunities.
    Hypertension. 2026;83:e27554.
    

    >> Share

    
    

    
    J Cardiovasc Pharmacol

14. BOGIN V, Weir MR
    Eplerenone Revisited: A Balanced Reappraisal of Its Role in Hypertension, Heart Failure, and Cardiorenal Disease.
    J Cardiovasc Pharmacol. 2026 Aug 19. doi: 10.1097/FJC.0000000000001875.
    

    >> Share

    
    

    
    J Hum Hypertens

15. NAKAYAMA T, Kaneko H, Suzuki Y, Okada A, et al
    Cardiovascular events with esaxerenone versus spironolactone in hypertension.
    J Hum Hypertens. 2026 Aug 20. doi: 10.1038/s41371-026-01200.
    

    >> Share

    
    
16. GALLO G, Tocci G, Nardoianni G, Cotugno M, et al
    Mitofusin 2 polymorphic variants and left ventricular hypertrophy in human hypertension.
    J Hum Hypertens. 2026 Aug 20. doi: 10.1038/s41371-026-01208.
    

    >> Share

    
    

    
    JAMA

17. ANDERER S
    Gestational Hypertension Has Increased, Affecting 1 in 10 Pregnancies.
    JAMA. 2026 Aug 21. doi: 10.1001/jama.2026.12057.
    

    >> Share

    
    

    
    PLoS One

18. GREENBERG JH, Ng DK, Sagiv E, Mitsnefes M, et al
    The Congenital Heart Disease in Children: Kidney-Associated Conditions with Epidemiologic Endpoints (CHICKADEE) study: Study design and protocol.
    PLoS One. 2026;21:e0356639.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share